Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer

Nitric Oxide - Biology and Chemistry

Volumn 27, Issue 3, 2012, Pages 185-191

  Koskela, Lotta Renström ^a,b   Poljakovic, Mirjana ^a,b   Ehrén, Ingrid ^a,b   Wiklund, N Peter ^a,b   De Verdier, Petra J ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BCG vaccine; Nitric oxide; Nitric oxide synthase type II; Urinary bladder neoplasms

Indexed keywords

BCG VACCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SUBMUCOSA; UROTHELIUM; WESTERN BLOTTING;

AGED; BCG VACCINE; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

MYCOBACTERIUM BOVIS BCG;

EID: 84864752234     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2012.07.001     Document Type: Article

References (34)

1. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Bohle, and J. Palou-Redorta EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur. Urol. 54 2008 303 314
2. H. Wolf, F. Melsen, S.E. Pedersen, and K.T. Nielsen Natural history of carcinoma in situ of the urinary bladder Scand. J. Urol. Nephrol. Suppl. 157 1994 147 151 (Pubitemid 24205663)
3. P. Gontero, A. Bohle, P.U. Malmstrom, M.A. O'Donnell, M. Oderda, R. Sylvester, and F. Witjes The role of bacillus Calmette-Guerin in the treatment of non-muscle-invasive bladder cancer Eur. Urol. 57 2010 410 429
4. A. Morales, D. Eidinger, and A.W. Bruce Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors J. Urol. 116 1976 180 183
5. T.L. Ratliff, D. Gillen, and W.J. Catalona Requirement of a thymus dependent immune response for BCG-mediated antitumor activity J. Urol. 137 1987 155 158 (Pubitemid 17214254)
6. J. Klostergaard, M.E. Leroux, and M.C. Hung Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro J. Immunol. 147 1991 2802 2808
7. A. Bohle, C. Nowc, A.J. Ulmer, J. Musehold, J. Gerdes, A.G. Hofstetter, and H.D. Flad Detection of urinary TNF, IL 1, and IL 2 after local BCG immunotherapy for bladder carcinoma Cytokine 2 1990 175 181
8. S. Prescott, K. James, T.B. Hargreave, G.D. Chisholm, and J.F. Smyth Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy J. Urol. 144 1990 1248 1251 (Pubitemid 20388099)
9. I.P. Oswald, T.A. Wynn, A. Sher, and S.L. James NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol. 108 1994 11 18 (Pubitemid 24172934)
10. J.B. Hibbs Jr., Z. Vavrin, and R.R. Taintor l-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells J. Immunol. 138 1987 550 565 (Pubitemid 17002220)
11. J.O. Lundberg, I. Ehren, O. Jansson, J. Adolfsson, J.M. Lundberg, E. Weitzberg, K. Alving, and N.P. Wiklund Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis Urology 48 1996 700 702 (Pubitemid 26398688)
12. R.G. Knowles, and S. Moncada Nitric oxide synthases in mammals Biochem. J. 298 Pt 2 1994 249 258 (Pubitemid 24072462)
13. I. Ehren, A. Hosseini, M. Herulf, J.O. Lundberg, and N.P. Wiklund Measurement of luminal nitric oxide in bladder inflammation using a silicon balloon catheter: a novel minimally invasive method Urology 54 1999 264 267 (Pubitemid 29367249)
14. http://www.gene-quantification.de/pfaffl-rel-quan-book-ch3.pdf.
15. P. Rajala, E. Kaasinen, E. Rintala, K. Jauhiainen, M. Nurmi, O. Alfthan, and M. Lahde Cytostatic effect of different strains of Bacillus Calmette-Guerin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alpha Urol. Res. 20 1992 215 217
16. S. Brandau, and H. Suttmann Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement Biomed. Pharmacother. 61 2007 299 305 (Pubitemid 47189735)
17. A. Hosseini, L.R. Koskela, I. Ehren, M. Aguilar-Santelises, A. Sirsjo, and N.P. Wiklund Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer Nitric Oxide 15 2006 337 343 (Pubitemid 44647888)
18. D. Mitropoulos, D. Petsis, A. Kyroudi-Voulgari, M. Kouloukoussa, A. Zervas, and C. Dimopoulos The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans Nitric Oxide 13 2005 36 41 (Pubitemid 40853967)
19. E. Morcos, O.T. Jansson, J. Adolfsson, I. Ehren, and N.P. Wiklund Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells J. Urol. 165 2001 678 682 (Pubitemid 32060499)
20. D.C. Jenkins, I.G. Charles, L.L. Thomsen, D.W. Moss, L.S. Holmes, S.A. Baylis, P. Rhodes, K. Westmore, P.C. Emson, and S. Moncada Roles of nitric oxide in tumor growth Proc. Natl. Acad. Sci. USA 92 1995 4392 4396
21. R. Farias-Eisner, M.P. Sherman, E. Aeberhard, and G. Chaudhuri Nitric oxide is an important mediator for tumoricidal activity in vivo Proc. Natl. Acad. Sci. USA 91 1994 9407 9411 (Pubitemid 24297923)
22. E. Morcos, O.T. Jansson, J. Adolfsson, G. Kratz, and N.P. Wiklund Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines Urology 53 1999 1252 1257 (Pubitemid 29264764)
23. O.T. Jansson, E. Morcos, L. Brundin, J.O. Lundberg, J. Adolfsson, M. Soderhall, and N.P. Wiklund The role of nitric oxide in bacillus Calmette-Guerin mediated anti-tumour effects in human bladder cancer Br. J. Cancer 78 1998 588 592
24. J.Y. Kwak, M.K. Han, K.S. Choi, I.H. Park, S.Y. Park, M.H. Sohn, U.H. Kim, J.R. McGregor, W.E. Samlowski, and C.Y. Yim Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells Cell. Immunol. 203 2000 84 94
25. W.H. Koppenol, J.J. Moreno, W.A. Pryor, H. Ischiropoulos, and J.S. Beckman Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide Chem. Res. Toxicol. 5 1992 834 842 (Pubitemid 23004874)
26. J.B. Hibbs Jr., R.R. Taintor, and Z. Vavrin Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages Biochem. Biophys. Res. Commun. 123 1984 716 723 (Pubitemid 14010149)
27. J.B. Hibbs Jr., R.R. Taintor, Z. Vavrin, and E.M. Rachlin Nitric oxide: a cytotoxic activated macrophage effector molecule Biochem. Biophys. Res. Commun. 157 1988 87 94 (Pubitemid 19004828)
28. M. Takema, K. Inaba, K. Uno, K. Kakihara, K. Tawara, and S. Muramatsu Effect of l-arginine on the retention of macrophage tumoricidal activity J. Immunol. 146 1991 1928 1933
29. B. Brune, C. Golkel, and A. von Knethen Cytokine and low-level nitric oxide prestimulation block p53 accumulation and apoptosis of RAW 264.7 macrophages Biochem. Biophys. Res. Commun. 229 1996 396 401 (Pubitemid 27029043)
30. H.S. Swana, S.D. Smith, P.L. Perrotta, N. Saito, M.A. Wheeler, and R.M. Weiss Inducible nitric oxide synthase with transitional cell carcinoma of the bladder J. Urol. 161 1999 630 634
31. T. Klotz, W. Bloch, G. Jacobs, S. Niggemann, U. Engelmann, and K. Addicks Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer Urology 54 1999 416 419 (Pubitemid 29407012)
32. E.O. Sandes, A.G. Faletti, M.D. Riveros, C. Vidal Mdel, L. Gimenez, A.R. Casabe, and A.M. Eijan Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patients Nitric Oxide 12 2005 39 45 (Pubitemid 41071408)
33. A. Bohle BCG's mechanism of action - increasing our understanding. For the EBIN Group. Eur. Urol. 37 Suppl 1 2000 1 8 (Pubitemid 30076957)
34. C. Durek, E. Richter, A. Basteck, S. Rusch-Gerdes, J. Gerdes, D. Jocham, and A. Bohle The fate of bacillus Calmette-Guerin after intravesical instillation J. Urol. 165 2001 1765 1768 (Pubitemid 32410305)